United States Senator Tim Kaine (Democrat of Virginia), left, and Berna Heyman, Wilson Disease Patient, And Retired Associate Dean Of Libraries, William & Mary, right, following her testimony before the United States Senate Committee on Aging hearing on ìValeant Pharmaceuticals' Business Model: the Repercussions for Patients and the Health Care Systemî on Capitol Hill in Washington, DC on Wednesday, April 27, 2016. Ms. Heyman, a patient with Wilson's Disease was forced to...
more »

United States Senator Tim Kaine (Democrat of Virginia), left, and Berna Heyman, Wilson Disease Patient, And Retired Associate Dean Of Libraries, William & Mary, right, following her testimony before the United States Senate Committee on Aging hearing on ìValeant Pharmaceuticals' Business Model: the Repercussions for Patients and the Health Care Systemî on Capitol Hill in Washington, DC on Wednesday, April 27, 2016. Ms. Heyman, a patient with Wilson's Disease was forced to stop using Syprine due to the 3,162 percent price increase ordered by Valeant Pharmaceuticals. Photo Credit: Ron Sachs/CNP/AdMedia
« less